Low Dose Heparin in the Prevention of Venons Thromboembolism^[*]

 

^* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.

• References

• 1 Ballard R. M. Low dose of subcutaneous heparin in the prevention of deep venous thrombosis after gynaecological surgery. Journal of Obstetrics and Gynaecology of the British Commonwealth 1973; 80: 469
• 2 Bauer G. Thirteen years’ experience with heparin therapy. In Koller Th, Merz W. R. (Eds.) Proceedings of the First International Conference on Thrombosis and Embolism. Schwabe Verlag, Basel p. 721 1954;
• 3 Blombäck B, Blombäck M, Hessel B, Iwanaga S. Structure of N- terminal fragments of fibrinogen and specificity of thrombin. Nature 1967; 215: 1445
• 4 Brinkhous K, Smith H. P, Warner E. D, Seegers W. H. The inhibition of blood clotting. An unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. American Journal of Physiology 1939; 125: 683
• 5 Corrigan T. P, Kakkar V. V, Fossard D. P. Low doses subcutaneous heparin - optimal dose regimen. British Journal of Surgery 1974; 61: 320
• 6 Dechavanne M, Ville D, Viala J. J, Kher A, Faivre J. et al. A controlled trial of heparin, aspirin and dipyridamole in prevention of deep vein thrombosis in patients undergoing total hip replacement. Personal communication. 1974
• 7 De Takats G. Anticoagulants in surgery. Journal of the American Medical Association 1950; 142: 527
• 8 Edinburgh Hospitals Trials (multiple authors) Heparin versus dextran in the prevention of od deep-vein thrombosis – A multi-unit controlled trial. Lancet 1974 2. 118
• 9 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis haemorrhagica 1965; 14: 473
• 10 Gallus A. S, Hirsh J, Tuttle R. J, Trebilcock R, O’Brien S. E. The use of small doses of heparin to prevent venous thrombosis in surgical and medical patients. New England Journal of Medicine 1973; 288: 545
• 11 Gordon-Smith I. C, Grundy D. J, Le Quesne L. P, Newcombe J. F, Bramble F. S. Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep vein thrombosis. A double blind randomized trial. Lancet 1972; 1: 1133
• 12 Griffith J. C, Boggs R. B. The clinical use of heparin. American Journal of Cardiology 1964; 39: 14
• 13 Han P, Ardlie N. G. Heparin, platelets and blood coagulation: Implication for low-dose heparin prophylactic regimens in venous thrombosis. British Journal of Haematology 27 1974; 253
• 14 Hume M, Sevitt S, Thomas D. P. Venous thrombosis and pulmonary embolism. Harvard University Press; Cambridge, Mass.: p. 3 1970
• 15 Hume M, Kuriakose T. X, Zuch L, Turner R. H. ¹²⁵I-fibrinogen and the prevention of venous thrombosis. Archives of Surgery 1973; 107: 803
• 16 Kakkar V. V. Low doses of heparin in the prevention of deep vein thrombosis. Bulletin of the Swiss Academy of Medical Sciences 1973; 29: 235
• 17 Kakkar V. V. Unpublished observations 1974
• 18 Kakkar V. V, Howe C. T, Laws J. W, Flanc C. Late results of treatment of deep vein thrombosis. British Medical Journal 1: 810 1969; a
• 19 Kakkar V. V, Howe C. T, Flanc C, Clarke M. B. The natural history of postoperative deep vein thrombosis. Lancet 2: 230 1969; b
• 20 Kakkar V. V, Field E. S, Nicolaides A. N, Flute P. T, Wessler S, Yin E. T. Low doses of heparin in the prevention of deep vein thrombosis. Lancet 1971; 2: 699
• 21 Kakkar V. V, Corrigan T. P, Spindler J, Fossard D. P, Flute P. T, Crellin R. Q, Wessler S, Yin E. T. Efficacy of low doses of heparin in prevention of deep vein thrombosis after major surgery. A double-blind randomized trial. Lancet 1972; 2: 101
• 22 Lenggenhager K. Genese and Prophylaxis der postoperativen Fernthrombose. Helvetica Chirurgica Acta 1957; 24: 316
• 23 Monkhouse F. C, France E. S, Seegers W. H. Studies on the antithrombin and heparin co-factor activities of a fraction absorbed from plasma by aluminium hydroxide. Circulation Research 1955; 3: 397
• 24 Morrell M. T, Truelove S. C, Barr A. Deep vein thrombosis and pulmonary embolism. British Medical Journal 1963; 2: 850
• 25 Nicolaides A. N, Dupont P. A, Desai S, Lewis J. D, Douglas J. N, Dodsworth H, Fourides G, Luck R. J, Jamieson C. W. Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 1972; 2: 890
• 26 Nicolaides A. N, Dupont P, Parsons D, Appleburg M, Horan F. T, Esah K. M, Walker C. J. Small doses subcutaneous sodium heparin in preventing deep venous thrombosis after elective hip surgery. British Journal of Surgery 1974; 61: 320
• 27 O’Brien J. R, Jamieson S, Etherington M, Klaber M. R. Platelet function in venous thrombosis and low dosage heparin. Lancet 1972; 1: 1301
• 28 Porter P, Porter M. C, Shanberge J. N. Interaction of heparin with the plasma protein in relation to its anti-thrombin activity. Biochemistry 1967; 6: 1854
• 29 Rosenberg R. D, Damus D. S. The purification and mechanism of action of human anti-thrombin heparin co-factor. Journal of Biological Chemistry 1973; 248: 6490
• 30 Sharnoff J. G, De Blasio G. Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 1970; 2: 1006
• 31 Sharnoff J. G, Kass H. H, Mistica B. A. A plasma heparinization of the surgical patients to prevent postoperative thrombo-embolism. Surgery, Gynecology and Obstetrics 1962; 115: 75
• 32 Sharnoff J. G, Bagg J. F, Breen S. R, Rogliano A. S, Walsh A. R, Scardino V. The possible indication of postoperative thrombo-embolism by platelet counts and blood coagulation studies in the patients undergoing extensive surgery. Surgery, Gynecology and Obstetrics 1960; 111: 469
• 33 Van Vroonhoven T. J. M. V, Van Ziji J, Muller H. Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep venous thrombosis. A controlled clinical trial. Lancet 1974; 1: 375
• 34 Wessler S. The theory and practice of mini-dose heparin in surgical patients: A status report. Circulation 1973; 47: 661
• 35 Williams H. T. Prevention of postoperative deep vein thrombosis with perioperative sucutaneous heparin. Lancet 1971; 2: 950
• 36 Yin E. T, Wessler S. Evidence for a naturally occuring plasma inhibitor of activated factor X: its isolation and partial purification. Thrombosis et Diathesis haemorrhagica 1969; 21: 398
• 37 Yin E. T, Wessler S, Stoll P. Identity of plasma-activated factor X inhibitor with antithrombin III and heparin co-factor. Journal of Biological Chemistry 1971; 246: 3712